These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22824730)

  • 21. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
    Goldwirt L; Lemaitre F; Zahr N; Farinotti R; Fernandez C
    J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversed phase liquid chromatography method with fluorescence detection of gemifloxacin in rat plasma and its application to the pharmacokinetic study.
    Kaiser M; Grünspan LD; Costa TD; Tasso L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3639-44. PubMed ID: 21963480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An improved HPLC method with fluorescence detection for the determination of pyrene in rat plasma and its pharmacokinetics.
    Zhao X; Wan J; Xu H; Yang X
    J Pharm Biomed Anal; 2008 Dec; 48(4):1237-42. PubMed ID: 18930619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Talanta; 2008 Sep; 76(5):1015-21. PubMed ID: 18761148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple RP-HPLC method for the simultaneous determination of curcumin and its prodrug, curcumin didecanoate, in rat plasma and the application to pharmacokinetic study.
    Han YR; Zhu JJ; Wang YR; Wang XS; Liao YH
    Biomed Chromatogr; 2011 Oct; 25(10):1144-9. PubMed ID: 21294139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor.
    Zhou J; Zhan Y; Zhong D; Chen X; Zhang Y; Zhang Q; Bo Y; Shen L; Gong J; Li J; Yang F
    J Sep Sci; 2021 Nov; 44(21):3959-3966. PubMed ID: 34472219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic assay for glucuronidation activity of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes.
    Hanioka N; Jinno H; Nishimura T; Ando M; Ozawa S; Sawada J
    Biomed Chromatogr; 2001 Aug; 15(5):328-33. PubMed ID: 11507714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined derivatization and high-performance liquid chromatography with fluorescence and ultraviolet detection for simultaneous analysis of octreotide and gabexate mesylate metabolite in human pancreatic juice samples.
    Carlucci G; Selvaggi F; Sulpizio S; Bassi C; Carlucci M; Cotellese R; Ferrone V; Innocenti P; Locatelli M
    Biomed Chromatogr; 2015 Jun; 29(6):911-7. PubMed ID: 25354693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sensitive and rapid liquid chromatography tandem mass spectrometry method for quantitative determination of 7-ethyl-10-hydroxycamptothecin (SN-38) in human plasma containing liposome-based SN-38 (LE-SN38).
    Khan S; Ahmad A; Ahmad I
    Biomed Chromatogr; 2003 Dec; 17(8):493-9. PubMed ID: 14648604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
    Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
    Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Method development and validation for simultaneous determination of lumefantrine and its major metabolite, desbutyl lumefantrine in human plasma using RP-HPLC/UV detection.
    Khuda F; Iqbal Z; Shah Y; Ahmmad L; Nasir F; Khan AZ; Amanullah ; Shahbaz N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():114-22. PubMed ID: 24316521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of CPT13 in rat plasma using LC-MS/MS for a pharmacokinetic study.
    Li QY; Su L; Zu YG; Zhang L; Gao Y; Wang CC; Zhu QC; Deng XQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):461-6. PubMed ID: 21296625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver.
    Platzer P; Thalhammer T; Reznicek G; Hamilton G; Zhang R; Jäger W
    Int J Oncol; 2001 Dec; 19(6):1287-93. PubMed ID: 11713602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
    Schoemaker NE; Rosing H; Jansen S; Schellens JH; Beijnen JH
    Ther Drug Monit; 2003 Feb; 25(1):120-4. PubMed ID: 12548157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecin derivative, in human plasma and urine.
    Smith JA; Hausheer F; Newman RA; Madden TL
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):117-24. PubMed ID: 11499615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple RP-HPLC method for quantification of columbianadin in rat plasma and its application to pharmacokinetic study.
    Zhang YB; Yang XW
    Biomed Chromatogr; 2010 Apr; 24(4):433-7. PubMed ID: 19662622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.
    Barilero I; Gandia D; Armand JP; Mathieu-Boué A; Ré M; Gouyette A; Chabot GG
    J Chromatogr; 1992 Mar; 575(2):275-80. PubMed ID: 1629304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
    Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid resolution liquid chromatography-mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one.
    Zhao YY; Qin XY; Cheng XL; Liu XY; Lin RC; Zhang Y; Li XY; Sun XL; Sun WJ
    Anal Chim Acta; 2010 Aug; 675(2):199-206. PubMed ID: 20800733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of an RP-HPLC method for the quantitation of odanacatib in rat and human plasma and its application to a pharmacokinetic study.
    Police A; Gurav S; Dhiman V; Zainuddin M; Bhamidipati RK; Rajagopal S; Mullangi R
    Biomed Chromatogr; 2015 Nov; 29(11):1664-9. PubMed ID: 25914381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.